Amedica: Regulatory Clearance for Valeo in Australia

Amedica has been granted marketing clearance in Australia for Valeo® silicon nitride ceramic interbody fusion devices.

Leadership notes that, in 1986-1988, Australian surgeons and engineers were the first to synthesize reaction-bonded silicon nitride and implant the material in lumbar spine fusion patients. Favorable outcomes were reported...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us